Gilead Sciences Inc (GILD)
65.54
+0.76
(+1.17%)
USD |
NASDAQ |
May 06, 16:00
65.45
-0.09
(-0.14%)
After-Hours: 20:00
Gilead Sciences Cash from Operations (Quarterly): 2.219B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.219B |
| December 31, 2023 | 2.169B |
| September 30, 2023 | 1.755B |
| June 30, 2023 | 2.338B |
| March 31, 2023 | 1.744B |
| December 31, 2022 | 2.567B |
| September 30, 2022 | 2.863B |
| June 30, 2022 | 1.802B |
| March 31, 2022 | 1.84B |
| December 31, 2021 | 3.205B |
| September 30, 2021 | 3.253B |
| June 30, 2021 | 2.316B |
| March 31, 2021 | 2.61B |
| December 31, 2020 | 1.916B |
| September 30, 2020 | 2.25B |
| June 30, 2020 | 2.566B |
| March 31, 2020 | 1.436B |
| December 31, 2019 | 2.58B |
| September 30, 2019 | 2.645B |
| June 30, 2019 | 2.342B |
| March 31, 2019 | 1.577B |
| December 31, 2018 | 2.345B |
| September 30, 2018 | 2.212B |
| June 30, 2018 | 1.573B |
| March 31, 2018 | 2.27B |
| Date | Value |
|---|---|
| December 31, 2017 | 2.753B |
| September 30, 2017 | 2.694B |
| June 30, 2017 | 3.526B |
| March 31, 2017 | 2.925B |
| December 31, 2016 | 3.539B |
| September 30, 2016 | 4.393B |
| June 30, 2016 | 4.985B |
| March 31, 2016 | 4.13B |
| December 31, 2015 | 5.795B |
| September 30, 2015 | 4.096B |
| June 30, 2015 | 5.658B |
| March 31, 2015 | 5.701B |
| December 31, 2014 | 3.021B |
| September 30, 2014 | 4.044B |
| June 30, 2014 | 4.185B |
| March 31, 2014 | 1.568B |
| December 31, 2013 | 726.80M |
| September 30, 2013 | 753.10M |
| June 30, 2013 | 953.00M |
| March 31, 2013 | 672.10M |
| December 31, 2012 | 706.01M |
| September 30, 2012 | 745.37M |
| June 30, 2012 | 1.291B |
| March 31, 2012 | 452.97M |
| December 31, 2011 | 978.11M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
1.436B
Minimum
Mar 2020
3.253B
Maximum
Sep 2021
2.321B
Average
2.327B
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 689.00M |
| CymaBay Therapeutics Inc (DELISTED) | -27.38M |
| Bristol-Myers Squibb Co | 2.834B |
| Eli Lilly and Co | 1.166B |
| Xilio Therapeutics Inc | -13.43M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.207B |
| Cash from Financing (Quarterly) | -1.361B |
| Free Cash Flow | 8.481B |
| Free Cash Flow Per Share (Quarterly) | 1.780 |
| Free Cash Flow to Equity (Quarterly) | 27.21B |
| Free Cash Flow to Firm (Quarterly) | 2.455B |
| Free Cash Flow Yield | 10.32% |